If you liked this article you might like

4 Biotech Names That Could Be M&A Targets
5 Rocket Stocks for 2017 -- Amgen, eBay, More
Here's Why Teva Shares Are Plummeting
Jim Cramer Sees Buying Opportunities in Praluent Patent Suit